Objective:To analyze the clinical outcome and feasibility for patients who underwent total parathyroidectomy without autotransplantation (TPTX) for secondary hyperparathyroidism (SHPT).Methods:From April 2012 to December 2015,220 SHPT patients underwent TPTX in the department of Breast and Thyroid Surgery of China-Japan Friendship Hospital.The clinical data and effect were assessed retrospectively.Results:All the 220 patients were on permanent dialysis with mean duration of dialysis (7.93 ± 3.75) years.A durable reduction in mean PTH,Ca and P were observed after TPTX (P＜0.01).The mean hospital stay was (7.8 ± 2.8) days.TPTX produced a rapid improvement in clinical symptoms.Incidence of hypocalcemia was 73.46％.Severe complications such as recurrent laryngeal nerve palsy or inactive dynamic osteopathia,haven't been observed postoperatively.The rate of persistent status (PTH≥300 pg/mL) was 9.1％.One (0.45％) died of infectious shock perioperatively.Conclusions:TPTX was a safe and feasible surgical procedure for patients with SHPT.It was worth of being applied.Not missing the parathyroid during operation was the key point for successful TPTX.Intensive monitoring and maintaining stable normocalcemia were the key point to reduce complication.

Objectives:To systematically analyze the effectiveness and safety of tranexamic acid(TXA)in or-thopedic surgery for patients with adolescent idiopathic scoliosis(AIS).Methods:Literature conceming the use of TXA in the orthopedic surgery of AIS patients of randomized controlled trial(RCT)and retrospective cohort studies(RCSs)were searched in the Cochrane library,Web of Science,Embase,PubMed,China National Knowledge Infrastructure(CNKI),and Wanfang Data Knowledge Service Platform,from the inception of the databases to December 2023.The quality of the included literature was evaluated by researchers according to Cochrane evaluation scale for RCT studies and Newcastle-Ottawa Scale(NOS)for RCS studies.The outcome indicators were extracted,including total blood loss,intraoperative blood loss,postoperative drainage,blood transfusion rate,postoperative hemoglobin(Hb)value,operation time,incidence of deep venous thrombosis and related complications.RevMan 5.4 software was used to analyze statistically the extracted data to evaluate the effect of TXA in orthopedic surgery for AIS patients.Results:A total of 8 RCT and 5 RCS studies were in cluded,and all of which were of high-quality,covering 855 patients,with 439 cases in the TXA group and 416 cases in the control group.Meta-analysis results showed that comparing with the control group,the TXA group was lower in intraoperative blood loss[mean difference(MD)=-310.81,95％confidence interval(CI)(-331.91,-289.72),P＜0.01],total blood loss[MD=-431.92,95％CI(-568.72,-295.13),P＜0.01],postoperative drainage[MD=-59.87,95％CI(-63.98,-55.75),P＜0.01],and the blood transfusion rate[odds ratio(OR)=0.17,95％CI(0.05,0.53),P=0.003];shorter in the operation time[MD=-5.94,95％CI(-10.73,-1.14),P=0.02]and higher in the Hb value after operation[MD=-0.40,95％CI(-0.26,0.54),P＜0.01].No deep venous thrombosis or related complications occurred in both groups.Conclusions:TXA can effectively reduce the intraoperative blood loss,total blood loss,postoperative drainage,blood transfusion rate and operation time in the orthopedic surgery of AIS patients,and maintain the postoperative Hb level without raising the likelihood of thrombosis and related complications.